Laboratory Corporation of America Holdings banner

Laboratory Corporation of America Holdings
NYSE:LH

Watchlist Manager
Laboratory Corporation of America Holdings Logo
Laboratory Corporation of America Holdings
NYSE:LH
Watchlist
Price: 255.84 USD -0.37% Market Closed
Market Cap: $21B

P/FCFE

627.8
Current
2 895%
More Expensive
vs 3-y average of 21

Price to Free Cash Flow to Equity (P/FCFE) ratio compares a company`s market value to the free cash flow available to its shareholders. It`s similar to the P/OCF ratio but more precise, since it accounts for capital expenditures deducted from operating cash flow.

P/FCFE
627.8
=
Market Cap
$23.5B
/
Free Cash Flow to Equity
$33.5m

Price to Free Cash Flow to Equity (P/FCFE) ratio compares a company`s market value to the free cash flow available to its shareholders. It`s similar to the P/OCF ratio but more precise, since it accounts for capital expenditures deducted from operating cash flow.

P/FCFE
627.8
=
Market Cap
$23.5B
/
Free Cash Flow to Equity
$33.5m

Valuation Scenarios

Laboratory Corporation of America Holdings is trading above its 3-year average

If P/FCFE returns to its 3-Year Average (21), the stock would be worth $8.54 (97% downside from current price).

Statistics
Positive Scenarios
0/4
Maximum Downside
-98%
Maximum Upside
No Upside Scenarios
Average Downside
97%
Scenario P/FCFE Value Implied Price Upside/Downside
Current Multiple 627.8 $255.84
0%
3-Year Average 21 $8.54
-97%
5-Year Average 13.6 $5.52
-98%
Industry Average 21.8 $8.89
-97%
Country Average 21.9 $8.91
-97%

Forward P/FCFE
Today’s price vs future free cash flow to equity

Not enough data available to calculate forward P/FCFE

Peer Comparison

All Multiples
P/FCFE
P/E
All Countries
Close

Market Distribution

Higher than 97% of companies in the United States of America
Percentile
97th
Based on 7 576 companies
97th percentile
627.8
Low
0 — 13.1
Typical Range
13.1 — 36.5
High
36.5 —
Distribution Statistics
the United States of America
Min 0
30th Percentile 13.1
Median 21.9
70th Percentile 36.5
Max 3 188 432.5

Laboratory Corporation of America Holdings
Glance View

Laboratory Corporation of America Holdings, commonly known as LabCorp, stands as a formidable player in the world of healthcare diagnostics. Emerging from a confluence of scientific innovation and business acumen, LabCorp has carved a niche within the intricate fabric of healthcare services. Since its inception, the company has excelled in offering a comprehensive suite of laboratory-based tests and services, empowering physicians and healthcare providers with critical insights needed for effective patient diagnosis and management. With its headquarters in Burlington, North Carolina, LabCorp operates a vast network of laboratories and patient service centers across the nation, providing services that range from routine blood work to sophisticated genomic testing. The essence of LabCorp’s business model lies in seamless integration across the healthcare continuum, driving both operational efficiency and profitability. Fundamentally, the company generates revenue by performing diagnostic tests on patient specimens, serving hospitals, managed care organizations, physician offices, and governmental agencies. As healthcare systems evolve towards precision medicine, LabCorp has harnessed emerging technologies and innovations like genomic testing to enhance its service offerings. This expansion not only aligns with changing healthcare paradigms but also fortifies its market leadership. By continually investing in research and development, LabCorp keeps its services at the cutting edge, ensuring steady growth and resilience in an ever-changing healthcare landscape.

LH Intrinsic Value
298.84 USD
Undervaluation 14%
Intrinsic Value
Price $255.84
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett